CBX4 has garnered extensive attention in cancer research, predominantly recognized as an oncogene due to its implications in tumor progression across various cancer types, including breast cancer [40], hepatocellular carcinoma [41], osteosarcoma [38], gastric cancer [42] and clear cell renal cell carcinoma [43]. This evidence concerns the gene CBX4 and clear cell renal carcinoma.